We are live on ! Find out more
BVS icon

Bioventus

144 hedge funds and large institutions have $448M invested in Bioventus in 2025 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 55 increasing their positions, 48 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more call options, than puts

Call options by funds: $823K | Put options by funds: $364K

68% more capital inflows, than outflows

Capital inflows: $40M | Capital outflows: $23.8M

15% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 48

1.68% more ownership

Funds ownership: 69.62% → 71.31% (+1.7%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

5% less funds holding

Funds holding: 151 → 144 (-7)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

Holders
144
Holders Change
-7
Holders Change %
-4.64%
% of All Funds
1.92%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
16
Increased
55
Reduced
48
Closed
23
Calls
$823​K
Puts
$364​K
Net Calls
+$459​K
Net Calls Change
-⁠$1.47​M

BVS Hedge Fund Activity: Q1 2025 in Review

144 of the 7,493 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q1 2025, worth a combined $448M — down 6.2% from $478M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of BVS and 16 opened new positions — a net loss of 7 holders — while 48 trimmed existing stakes and 55 added.

The largest buyer was Divisadero Street Capital Management, opening a new position worth an estimated $16.9M. The largest seller was Ophir Asset Management, exiting entirely with an estimated $4.46M sold.

  • 144 institutional investors held Bioventus (BVS) as of Q1 2025, down from 151 in Q4 2024.
  • Funds reported $448M of Bioventus stock for Q1 2025, down 6.2% quarter-over-quarter.
  • 16 funds opened new Bioventus positions in Q1 2025 and 23 closed out, a net change of -7 holders.
  • The largest Bioventus buyer in Q1 2025 was Divisadero Street Capital Management, an estimated $16.9M added.
  • The largest Bioventus seller in Q1 2025 was Ophir Asset Management, an estimated $4.46M sold.

Based on aggregated 13F filings for Q1 2025.